Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

368 – Safety and Antiviral Activity of CD4 Mimetic Treatment in SHIV-Infected Rhesus Macaques

By Jimmy He PharmD, DScMarch 31, 2026

…RMs model, with a modest but measurable effect in reducing the levels of infected CD4+ T-cells. Ongoing NK assay to measure ADCC activity will provide mechanistic data. These findings inform…

778 – HeCaPred: An AI-Based Algorithm for HCC Prediction in Patients With HCV Chronic Infection After SVR

By Jimmy He PharmD, DScMarch 20, 2025

…the sensitivity (Se) and negative predictive value (NPV), regarding only the classification made by that node. Results 1.033 patients were included, 597 (58%) were living with HIV. The median (Q1-Q3)…

HIV DYNAMICS AND REPOPULATION OF RESERVOIRS IN THE HUMAN BODY

By Jimmy He PharmD, DScApril 28, 2020

…in the occipital lobe (interquartile range: [IQR] 0-4.6) to 659 cp/106 cells in lymph nodes (IQR 580-753), mean=98 cp/106 cells (IQR:23-132) across all tissues. We recovered 603 intact FL env…

INCIDENT INFECTION IN HIGH-PRIORITY HIV MOLECULAR TRANSMISSION CLUSTERS

By Enthusiast Inc MDMarch 6, 2019

…cases diagnosed in 2012). We then identified cases diagnosed through 2017 that were genetically linked to these clusters, representing cluster growth in the 5 years after prioritization. We performed Bayesian…

DEEP LEARNING APPROACHES TO INFORM NETWORK-BASED HIV INTERVENTIONS AMONG PWID

By Jimmy He PharmD, DScApril 4, 2022

…over 20 km in New Delhi and formed one large network when accounting for social and spatial ties. Injection networks were highly dynamic (75% gained/lost a partner over a median…

CYTOF CHARACTERIZATION OF THE IN VIVO LATENT HIV RESERVOIR IN BLOOD AND TISSUES

By Enthusiast Inc MDMarch 5, 2019

…was first confirmed in an in vitro model of HIV latency. Then, freshly isolated blood and lymph node cells from ART-suppressed, HIV-infected individuals from the SCOPE cohort were stimulated with…

FULLY MHC-MATCHED ALLOGENEIC HSCT IN SIV-INFECTED, ART-SUPPRESSED MACAQUES

By Enthusiast Inc MDMarch 5, 2018

…of fully MHC-matched allogeneic HSCT to investigate the mechanism of cure in Timothy Brown. In this model, a reduced intensity conditioning (RIC) regimen consisting of chemotherapy, CD3 depletion, and total…

FTY720 LIMITS T FOLLICULAR HELPER CELL INFECTION IN LYMPHOID SITES OF SIV PERSISTENCE

By Enthusiast Inc MDMarch 7, 2019

…T cell egress from LN resulted in a measurable decrease of SIV-DNA and -RNA content in LN Tfh cells in most treated animals as measured by RNAscope (p=0.02; n=6) and…

430 – Dual Receptor-Targeted LNPs Enhance HIV-1 Proviral DNA Excision

By Jimmy He PharmD, DScMarch 31, 2026

…cure. Methods CCR5 receptor-targeted lipid nanoparticles (M5-LNPs) encapsulating CRISPR-Cas9 and gRNA were formulated using microfluidics; untargeted C-LNPs served as controls. The RiboGreen assay determined the mRNA encapsulation efficiency. LNP size…

Using HIV Networks to Inform Real Time Prevention Interventions

By Enthusiast Inc MDSeptember 29, 2014

Background: Understanding the dynamics of HIV transmission may provide opportunities for public health interventions. Methodology: We inferred a partial local transmission network among 478 recently HIV infected persons and 170…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849
…5051525354…
55565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top